ADAP

Adaptimmune Therapeutics PLCCIK 1621227 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ADAP PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ADAP

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Wood Gavin	Chief Financial Officer	15	$81.3K	$960	2025-09-02
Bertrand William C JR	Chief Operating Officer	39	$142.8K	$199.8K	2025-08-28
Behbahani Ali	Director	14	$25.07M	$195.0K	2025-08-18
EcoR1 Capital, LLC	10% Owner	3	$0	$6.74M	2025-07-30
Brewer Joanna Elizabeth	Chief Scientific Officer	9	$0	$0	2025-02-20
Piccina Cintia	Chief Commercial Officer	11	$0	$89.7K	2025-02-20
Norry Elliot	Chief Medical Officer	34	$0	$118.1K	2025-02-20
Lunger John	Chief Patient Supply Officer	43	$0	$217.9K	2025-02-20
Rawcliffe Adrian	Chief Financial Officer	52	$0	$1.55M	2025-02-20
Hegde Priti	Director	5	$0	$0	2024-07-01
Furey John	Director	6	$0	$0	2024-07-01
Menzel Garry E	Director	13	$0	$43.4K	2024-07-01
Alleva Lawrence M	Director	12	$74.1K	$0	2024-07-01
Allen Andrew R	Director	8	$0	$0	2024-07-01
Hege Kristen	Director	2	$0	$0	2024-07-01
MOTT DAVID M	Director, 10% Owner	18	$54.10M	$0	2024-07-01
TAYTON-MARTIN HELEN KATRINA	Chief Operating Officer	18	$0	$2.20M	2024-01-15
Sigal Charles Elliott	Director	12	$92.1K	$0	2023-07-03
Zaks Tal Zvi	Director	7	$0	$0	2022-07-01
Noble James	Director	14	$0	$6.07M	2022-07-01
Duncan Barbara Gayle	Director	6	$0	$0	2022-07-01
Florence Anthony A. Jr.	10% Owner	9	$54.10M	$0	2020-01-24
Sonsini Peter W.	10% Owner	9	$54.10M	$0	2020-01-24
BASKETT FOREST	10% Owner	9	$54.10M	$0	2020-01-24
SANDELL SCOTT D	10% Owner	9	$54.10M	$0	2020-01-24
Amado Rafael	President, R&D	9	$0	$39.0K	2019-08-06
Kerr Giles Francis Bertram	Director	4	$0	$0	2019-07-02
Binder-Scholl Gwendolyn Knowlton	EVP, Adaptimmune LLC	7	$0	$609.1K	2019-01-14
NEA 14 GP, LTD	10% Owner	5	$16.43M	$0	2018-09-07
Viswanathan Ravi	10% Owner	8	$49.08M	$0	2018-09-07
KERINS PATRICK J	10% Owner	7	$29.04M	$0	2018-09-07
BARRETT M JAMES	10% Owner	7	$29.04M	$0	2018-09-07
BARRIS PETER J	10% Owner	8	$49.08M	$0	2018-09-07
OrbiMed Capital GP V LLC	Director	5	$0	$2.70M	2018-06-06
Thompson Peter A.	Director	13	$22.85M	$14.76M	2018-06-06
ORBIMED ADVISORS LLC	Director	5	$17.85M	$12.05M	2018-03-29
NEA Partners 14, L.P.	10% Owner	2	$12.61M	$0	2018-03-27
ISALY SAMUEL D	Director	1	$5.00M	$0	2017-03-27
Knowles Jonathan Kenneth Charles	Director	1	$0	$0	2016-08-11
Laing Ian Michael	Director	1	$0	$0	2016-08-11

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Wood Gavin	Chief Financial Officer	S Sale	2025-09-02	2025-09-03	96,000	$0.01	$960	0	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2025-08-28	2025-08-29	207,000	$0.01	$2.1K	986,352	SEC↗
Behbahani Ali	Director	S Sale	2025-08-18	2025-08-19	14,671,794	$0.01	$146.7K	0	SEC↗
Behbahani Ali	Director	S Sale	2025-08-15	2025-08-19	4,828,206	$0.01	$48.3K	14,671,794	SEC↗
EcoR1 Capital, LLC	10% Owner	S Sale	2025-07-30	2025-07-30	27,433,338	$0.10	$2.74M	100,371,882	SEC↗
EcoR1 Capital, LLC	10% Owner	S Sale	2025-07-29	2025-07-30	2,687,460	$0.10	$268.7K	127,805,220	SEC↗
EcoR1 Capital, LLC	10% Owner	S Sale	2025-07-28	2025-07-30	33,931,740	$0.11	$3.73M	130,492,680	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2025-02-20	2025-02-20	3,428,832	—	$0	3,428,832	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2025-02-20	2025-02-20	5,143,248	—	$0	5,143,248	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2025-02-20	2025-02-20	1,612,032	—	$0	1,612,032	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2025-02-20	2025-02-20	1,074,696	—	$0	1,074,696	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2025-02-20	2025-02-20	1,074,696	—	$0	1,074,696	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2025-02-20	2025-02-20	1,612,032	—	$0	1,612,032	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2025-02-20	2025-02-20	1,074,696	—	$0	1,074,696	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2025-02-20	2025-02-20	1,612,032	—	$0	1,612,032	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2025-02-20	2025-02-20	1,612,032	—	$0	1,612,032	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2025-02-20	2025-02-20	1,074,696	—	$0	1,074,696	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2025-02-20	2025-02-20	1,074,696	—	$0	1,074,696	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2025-02-20	2025-02-20	1,612,032	—	$0	1,612,032	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2025-01-17	2025-01-17	30,601	$0.58	$17.7K	44,327	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2025-01-17	2025-01-17	5,584	$0.58	$3.2K	7,510	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2025-01-17	2025-01-17	5,584	$0.58	$3.2K	7,510	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2025-01-17	2025-01-17	5,584	$0.58	$3.2K	7,510	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2025-01-15	2025-01-15	9,803	$0.57	$5.6K	13,756	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2025-01-15	2025-01-15	9,803	$0.57	$5.6K	13,756	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2025-01-15	2025-01-15	9,803	$0.57	$5.6K	13,756	SEC↗
Piccina Cintia	Chief Commercial Officer	S Sale	2025-01-15	2025-01-15	12,991	$0.57	$7.4K	18,421	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2025-01-15	2025-01-15	29,096	$0.57	$16.6K	41,582	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2025-01-13	2025-01-15	4,268	$0.59	$2.5K	5,845	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2025-01-13	2025-01-15	5,471	$0.59	$3.2K	7,623	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2025-01-13	2025-01-15	4,268	$0.59	$2.5K	5,845	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2025-01-13	2025-01-15	5,471	$0.59	$3.2K	7,623	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2025-01-13	2025-01-15	8,124	$0.59	$4.8K	11,516	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2025-01-13	2025-01-15	4,268	$0.59	$2.5K	5,845	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2025-01-13	2025-01-15	17,934	$0.59	$10.6K	25,711	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2025-01-13	2025-01-15	12,539	$0.59	$7.4K	17,801	SEC↗
Allen Andrew R	Director	A Award deriv	2024-07-01	2024-07-01	660,000	—	$0	660,000	SEC↗
Alleva Lawrence M	Director	A Award deriv	2024-07-01	2024-07-01	1,213,926	—	$0	1,213,926	SEC↗
Furey John	Director	A Award deriv	2024-07-01	2024-07-01	660,000	—	$0	660,000	SEC↗
Hegde Priti	Director	A Award deriv	2024-07-01	2024-07-01	1,144,686	—	$0	1,144,686	SEC↗
Hege Kristen	Director	A Award deriv	2024-07-01	2024-07-01	660,000	—	$0	660,000	SEC↗
Menzel Garry E	Director	A Award deriv	2024-07-01	2024-07-01	1,121,604	—	$0	1,121,604	SEC↗
MOTT DAVID M	Director	A Award deriv	2024-07-01	2024-07-01	1,583,214	—	$0	1,583,214	SEC↗
Behbahani Ali	Director	A Award deriv	2024-07-01	2024-07-01	1,144,686	—	$0	1,144,686	SEC↗
Piccina Cintia	Chief Commercial Officer	S Sale	2024-06-18	2024-06-18	24,531	$0.93	$22.8K	38,293	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2024-03-18	2024-03-18	5,088,864	—	$0	5,088,864	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2024-03-18	2024-03-18	1,130,832	—	$0	1,130,832	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2024-01-17	2024-01-17	5,309	$0.67	$3.6K	7,785	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2024-01-17	2024-01-17	13,599	$0.67	$9.1K	20,201	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2024-01-17	2024-01-17	12,805	$0.67	$8.6K	19,015	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2024-01-17	2024-01-17	5,309	$0.67	$3.6K	7,785	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2024-01-17	2024-01-17	12,967	$0.67	$8.7K	19,257	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2024-01-17	2024-01-17	5,309	$0.67	$3.6K	7,785	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2024-01-17	2024-01-17	30,080	$0.67	$20.2K	44,848	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2024-01-16	2024-01-17	4,681	$0.79	$3.7K	7,023	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2024-01-16	2024-01-17	4,681	$0.79	$3.7K	7,023	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2024-01-16	2024-01-17	2,287	$0.79	$1.8K	3,363	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2024-01-16	2024-01-17	9,304	$0.79	$7.4K	14,104	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2024-01-15	2024-01-17	1,696,272	—	$0	1,696,272	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2024-01-15	2024-01-17	7,633,296	—	$0	7,633,296	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business & Strgy Offic	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business & Strgy Offic	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
Hege Kristen	Director	A Award deriv	2024-01-15	2024-01-17	81,906	—	$0	81,906	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2024-01-15	2024-01-17	2,544,432	—	$0	2,544,432	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2024-01-15	2024-01-17	565,416	—	$0	565,416	SEC↗
Behbahani Ali	Director	A Award deriv	2024-01-15	2024-01-17	40,950	—	$0	40,950	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2024-01-12	2024-01-12	7,799	$0.85	$6.6K	11,841	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2024-01-12	2024-01-12	5,220	$0.85	$4.4K	7,874	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2024-01-12	2024-01-12	17,257	$0.85	$14.7K	26,388	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2024-01-12	2024-01-12	5,220	$0.85	$4.4K	7,874	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2024-01-11	2024-01-12	4,009	$0.84	$3.4K	6,104	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2024-01-11	2024-01-12	4,009	$0.84	$3.4K	6,104	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2024-01-11	2024-01-12	11,945	$0.84	$10.0K	18,395	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2024-01-11	2024-01-12	4,009	$0.84	$3.4K	6,104	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-09-01	2023-09-01	2,403	$0.78	$1.9K	3,449	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2023-08-01	2023-08-01	3,096	$0.91	$2.8K	4,718	SEC↗
Menzel Garry E	Director	S Sale	2023-07-10	2023-07-10	47,702	$0.91	$43.4K	75,056	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	2,158,776	—	$0	2,158,776	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	736,548	—	$0	736,548	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	1,251,966	—	$0	1,251,966	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	359,700	—	$0	359,700	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	3,568,026	—	$0	3,568,026	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	57,846	—	$0	57,846	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-05	2023-07-05	2,715,816	—	$0	2,715,816	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	73,212	—	$0	73,212	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	45,348	—	$0	45,348	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	109,746	—	$0	109,746	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	109,746	—	$0	109,746	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	152,376	—	$0	152,376	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-05	2023-07-05	56,868	—	$0	56,868	SEC↗
Hegde Priti	Director	A Award deriv	2023-07-05	2023-07-05	152,376	—	$0	152,376	SEC↗
Hegde Priti	Director	A Award deriv	2023-07-05	2023-07-05	109,746	—	$0	109,746	SEC↗
Hegde Priti	Director	A Award deriv	2023-07-05	2023-07-05	226,464	—	$0	226,464	SEC↗
Allen Andrew R	Director	A Award deriv	2023-07-03	2023-07-03	500,000	—	$0	500,000	SEC↗
MOTT DAVID M	Director	A Award deriv	2023-07-03	2023-07-03	1,462,927	—	$0	1,462,927	SEC↗
Alleva Lawrence M	Director	A Award deriv	2023-07-03	2023-07-03	1,077,756	—	$0	1,077,756	SEC↗
Sigal Charles Elliott	Director	A Award deriv	2023-07-03	2023-07-03	933,317	—	$0	933,317	SEC↗
Menzel Garry E	Director	A Award deriv	2023-07-03	2023-07-03	981,463	—	$0	981,463	SEC↗
Furey John	Director	A Award deriv	2023-07-03	2023-07-03	500,000	—	$0	500,000	SEC↗
Hegde Priti	Director	A Award deriv	2023-07-03	2023-07-03	500,000	—	$0	500,000	SEC↗
Behbahani Ali	Director	A Award deriv	2023-07-03	2023-07-03	933,317	—	$0	933,317	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-06-27	2023-06-27	2,333	$0.92	$2.1K	3,519	SEC↗
Menzel Garry E	Director	A Award	2023-06-01	2023-06-01	200,646	—	$0	200,646	SEC↗
Menzel Garry E	Director	A Award	2023-06-01	2023-06-01	200,647	—	$0	200,647	SEC↗
Menzel Garry E	Director	A Award	2023-06-01	2023-06-01	209,931	—	$0	209,931	SEC↗
Piccina Cintia	Chief Commercial Officer	S Sale	2023-01-31	2023-01-31	11,890	$1.87	$22.2K	19,535	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2023-01-17	2023-01-17	1,798,272	—	$0	1,798,272	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2023-01-17	2023-01-17	4,690,224	—	$0	4,690,224	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2023-01-17	2023-01-17	1,407,072	—	$0	1,407,072	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2023-01-17	2023-01-17	314,256	—	$0	314,256	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2023-01-17	2023-01-17	193,344	—	$0	193,344	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2023-01-17	2023-01-17	1,407,072	—	$0	1,407,072	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2023-01-17	2023-01-17	314,256	—	$0	314,256	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2023-01-17	2023-01-17	193,728	—	$0	193,728	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2023-01-17	2023-01-17	1,407,072	—	$0	1,407,072	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2023-01-17	2023-01-17	314,256	—	$0	314,256	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2023-01-17	2023-01-17	135,480	—	$0	135,480	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2023-01-17	2023-01-17	190,920	—	$0	190,920	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2023-01-17	2023-01-17	314,256	—	$0	314,256	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2023-01-17	2023-01-17	1,407,072	—	$0	1,407,072	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-01-17	2023-01-17	10,057	$1.86	$18.7K	13,351	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2023-01-17	2023-01-17	2,159	$1.86	$4.0K	3,491	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2023-01-17	2023-01-17	4,440	$1.86	$8.3K	7,264	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2023-01-17	2023-01-17	4,440	$1.86	$8.3K	7,264	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-01-12	2023-01-12	18,763	$1.71	$32.1K	24,882	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2023-01-12	2023-01-12	7,449	$1.71	$12.7K	12,191	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2023-01-12	2023-01-12	4,973	$1.71	$8.5K	8,121	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2023-01-12	2023-01-12	4,973	$1.71	$8.5K	8,121	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-01-11	2023-01-12	13,042	$1.75	$22.8K	17,298	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2023-01-11	2023-01-12	3,843	$1.75	$6.7K	6,270	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2023-01-11	2023-01-12	3,843	$1.75	$6.7K	6,270	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2023-01-11	2023-01-12	3,843	$1.75	$6.7K	6,270	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2023-01-04	2023-01-04	5,073	$1.69	$8.6K	6,631	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2023-01-04	2023-01-04	876	$1.69	$1.5K	1,361	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2023-01-04	2023-01-04	1,100	$1.69	$1.9K	1,725	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2023-01-04	2023-01-04	3,584	$1.69	$6.1K	5,781	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-09-01	2022-09-01	2,536	$1.97	$5.0K	3,316	SEC↗
Piccina Cintia	Chief Commercial Officer	S Sale	2022-08-01	2022-08-01	21,040	$1.77	$37.2K	34,824	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-08-01	2022-08-01	2,983	$1.77	$5.3K	4,829	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-07-05	2022-07-05	1,973	$1.68	$3.3K	3,104	SEC↗
MOTT DAVID M	Director	A Award deriv	2022-07-01	2022-07-01	1,000,439	—	$0	1,000,439	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2022-07-01	2022-07-01	500,000	—	$0	500,000	SEC↗
Sigal Charles Elliott	Director	A Award deriv	2022-07-01	2022-07-01	737,050	—	$0	737,050	SEC↗
Noble James	Director	A Award deriv	2022-07-01	2022-07-01	710,711	—	$0	710,711	SEC↗
Furey John	Director	A Award deriv	2022-07-01	2022-07-01	500,000	—	$0	500,000	SEC↗
Alleva Lawrence M	Director	A Award deriv	2022-07-01	2022-07-01	816,067	—	$0	816,067	SEC↗
Zaks Tal Zvi	Director	A Award deriv	2022-07-01	2022-07-01	500,000	—	$0	500,000	SEC↗
Behbahani Ali	Director	A Award deriv	2022-07-01	2022-07-01	737,050	—	$0	737,050	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-06-27	2022-06-27	2,562	$1.63	$4.2K	3,290	SEC↗
Wood Gavin	Chief Financial Officer	P Buy	2022-05-20	2022-05-23	39,000	$0.29	$11.3K	96,000	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2022-05-04	2022-05-04	223,512	—	$0	223,512	SEC↗
Brewer Joanna Elizabeth	Chief Scientific Officer	A Award deriv	2022-05-04	2022-05-04	333,792	—	$0	333,792	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2022-01-31	2022-01-31	335,184	—	$0	335,184	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2022-01-31	2022-01-31	3,376,992	—	$0	3,376,992	SEC↗
Piccina Cintia	Chief Commercial Officer	A Award deriv	2022-01-31	2022-01-31	754,200	—	$0	754,200	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-01-18	2022-01-18	11,096	$3.19	$35.4K	12,312	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2022-01-18	2022-01-18	2,121	$3.19	$6.8K	3,529	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-01-18	2022-01-18	4,368	$3.19	$13.9K	7,336	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2022-01-18	2022-01-18	4,368	$3.19	$13.9K	7,336	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2022-01-12	2022-01-13	1,047,480	—	$0	1,047,480	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2022-01-12	2022-01-13	4,690,224	—	$0	4,690,224	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2022-01-12	2022-01-13	314,256	—	$0	314,256	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2022-01-12	2022-01-13	1,407,072	—	$0	1,407,072	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2022-01-12	2022-01-13	2,110,608	—	$0	2,110,608	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2022-01-12	2022-01-13	471,360	—	$0	471,360	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2022-01-12	2022-01-13	314,256	—	$0	314,256	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2022-01-12	2022-01-13	1,407,072	—	$0	1,407,072	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2022-01-12	2022-01-13	314,256	—	$0	314,256	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2022-01-12	2022-01-13	1,407,072	—	$0	1,407,072	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2022-01-12	2022-01-13	1,407,072	—	$0	1,407,072	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2022-01-12	2022-01-13	314,256	—	$0	314,256	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-01-12	2022-01-13	3,046	$3.54	$10.8K	3,356	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2022-01-12	2022-01-13	854	$3.54	$3.0K	1,383	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-01-12	2022-01-13	1,076	$3.54	$3.8K	1,749	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2022-01-12	2022-01-13	2,248	$3.54	$8.0K	3,754	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-01-11	2022-01-13	14,362	$3.56	$51.1K	15,978	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2022-01-11	2022-01-13	3,770	$3.56	$13.4K	6,343	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-01-11	2022-01-13	3,770	$3.56	$13.4K	6,343	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2022-01-11	2022-01-13	3,770	$3.56	$13.4K	6,343	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2022-01-04	2022-01-05	5,532	$4.06	$22.5K	6,172	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2022-01-04	2022-01-05	849	$4.06	$3.4K	1,388	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2022-01-04	2022-01-05	1,070	$4.06	$4.3K	1,755	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2022-01-04	2022-01-05	3,490	$4.06	$14.2K	5,873	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2021-08-02	2021-08-02	2,939	$3.58	$10.5K	4,873	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2021-07-02	2021-07-02	1,907	$4.26	$8.1K	3,170	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2021-07-02	2021-07-02	4,375	$4.26	$18.6K	7,329	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2021-07-01	2021-07-02	379,788	—	$0	379,788	SEC↗
Behbahani Ali	Director	A Award deriv	2021-07-01	2021-07-02	474,385	—	$0	474,385	SEC↗
MOTT DAVID M	Director	A Award deriv	2021-07-01	2021-07-02	579,494	—	$0	579,494	SEC↗
Sigal Charles Elliott	Director	A Award deriv	2021-07-01	2021-07-02	474,385	—	$0	474,385	SEC↗
Noble James	Director	A Award deriv	2021-07-01	2021-07-02	379,788	—	$0	379,788	SEC↗
Furey John	Director	A Award deriv	2021-07-01	2021-07-02	379,788	—	$0	379,788	SEC↗
Alleva Lawrence M	Director	A Award deriv	2021-07-01	2021-07-02	505,918	—	$0	505,918	SEC↗
Zaks Tal Zvi	Director	A Award deriv	2021-07-01	2021-07-02	379,788	—	$0	379,788	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2021-06-28	2021-06-28	2,794	$4.37	$12.2K	3,058	SEC↗
Alleva Lawrence M	Director	P Buy	2021-06-01	2021-06-03	12,600	$0.79	$10.0K	12,600	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	M Exercise	2021-03-03	2021-03-03	1,785,000	$0.16	$285.6K	1,800,000	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2021-01-19	2021-01-19	9,879	$5.67	$56.0K	13,529	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2021-01-19	2021-01-19	4,358	$5.67	$24.7K	7,346	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2021-01-19	2021-01-19	2,111	$5.67	$12.0K	3,539	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2021-01-12	2021-01-12	2,707	$6.15	$16.6K	3,695	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2021-01-12	2021-01-12	841	$6.15	$5.2K	1,396	SEC↗
	Chief Patient Supply Officer	S Sale	2021-01-12	2021-01-12	1,058	$6.15	$6.5K	1,767	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2021-01-12	2021-01-12	2,234	$6.15	$13.7K	3,768	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2021-01-11	2021-01-11	728,160	—	$0	728,160	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2021-01-11	2021-01-11	3,260,400	—	$0	3,260,400	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2021-01-11	2021-01-11	242,712	—	$0	242,712	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2021-01-11	2021-01-11	1,086,816	—	$0	1,086,816	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2021-01-04	2021-01-05	4,967	$5.33	$26.5K	6,737	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2021-01-04	2021-01-05	845	$5.33	$4.5K	1,392	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2021-01-04	2021-01-05	3,499	$5.33	$18.6K	5,864	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2021-01-04	2021-01-05	1,065	$5.33	$5.7K	1,760	SEC↗
Bertrand William C JR	Chief Operating Officer	P Buy	2020-12-14	2020-12-15	207,000	$0.69	$142.8K	284,808	SEC↗
Wood Gavin	Chief Financial Officer	P Buy	2020-12-14	2020-12-16	24,000	$0.69	$16.6K	57,000	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2020-09-01	2020-09-02	2,776	$8.51	$23.6K	3,076	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2020-08-03	2020-08-04	2,788	$9.25	$25.8K	3,064	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	S Sale	2020-08-03	2020-08-04	200,000	$8.74	$1.75M	0	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2020-08-03	2020-08-04	4,823	$9.25	$44.6K	8,066	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2020-07-01	2020-07-01	144,000	—	$0	144,000	SEC↗
MOTT DAVID M	Director	A Award deriv	2020-07-01	2020-07-01	226,753	—	$0	226,753	SEC↗
Sigal Charles Elliott	Director	A Award deriv	2020-07-01	2020-07-01	184,258	—	$0	184,258	SEC↗
Noble James	Director	A Award deriv	2020-07-01	2020-07-01	179,785	—	$0	179,785	SEC↗
Furey John	Director	A Award deriv	2020-07-01	2020-07-01	196,186	—	$0	196,186	SEC↗
Alleva Lawrence M	Director	A Award deriv	2020-07-01	2020-07-01	197,678	—	$0	197,678	SEC↗
Zaks Tal Zvi	Director	A Award deriv	2020-07-01	2020-07-01	144,000	—	$0	144,000	SEC↗
Behbahani Ali	Director	A Award deriv	2020-07-01	2020-07-01	184,258	—	$0	184,258	SEC↗
Wood Gavin	Chief Financial Officer	P Buy	2020-06-29	2020-06-30	33,000	$1.62	$53.5K	33,000	SEC↗
Alleva Lawrence M	Director	P Buy	2020-06-09	2020-06-11	12,900	$1.89	$24.4K	12,900	SEC↗
Noble James	Director	S Sale	2020-05-29	2020-06-02	500,000	$9.33	$4.67M	0	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2020-04-01	2020-04-01	2,500,000	—	$0	2,500,000	SEC↗
Wood Gavin	Chief Financial Officer	A Award deriv	2020-04-01	2020-04-01	565,000	—	$0	565,000	SEC↗
Noble James	Director	A Award deriv	2020-04-01	2020-04-01	31,000	—	$0	31,000	SEC↗
BASKETT FOREST	10% Owner	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
Behbahani Ali	Director	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
Florence Anthony A. Jr.	10% Owner	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
MOTT DAVID M	Director, 10% Owner	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
SANDELL SCOTT D	10% Owner	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
Sonsini Peter W.	10% Owner	P Buy	2020-01-24	2020-01-28	7,500,000	$0.67	$5.03M	19,500,000	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2020-01-16	2020-01-17	2,515,536	—	$0	2,515,536	SEC↗
Rawcliffe Adrian	Chief Executive Officer	A Award deriv	2020-01-16	2020-01-17	561,792	—	$0	561,792	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2020-01-16	2020-01-17	1,257,744	—	$0	1,257,744	SEC↗
Bertrand William C JR	Chief Operating Officer	A Award deriv	2020-01-16	2020-01-17	280,896	—	$0	280,896	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2020-01-16	2020-01-17	1,257,744	—	$0	1,257,744	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2020-01-16	2020-01-17	280,896	—	$0	280,896	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2020-01-16	2020-01-17	1,257,744	—	$0	1,257,744	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	A Award deriv	2020-01-16	2020-01-17	280,896	—	$0	280,896	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2020-01-16	2020-01-17	135,600	—	$0	135,600	SEC↗
Norry Elliot	Chief Medical Officer	A Award deriv	2020-01-16	2020-01-17	201,600	—	$0	201,600	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2020-01-14	2020-01-15	3,236	$5.13	$16.6K	3,166	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2020-01-14	2020-01-15	1,144	$5.13	$5.9K	1,681	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2020-01-14	2020-01-15	2,397	$5.13	$12.3K	3,605	SEC↗
Norry Elliot	Chief Medical Officer	S Sale	2020-01-14	2020-01-15	911	$5.13	$4.7K	1,326	SEC↗
Noble James	Director	S Sale	2020-01-13	2020-01-15	200,000	$5.00	$1.00M	0	SEC↗
Noble James	Director	S Sale	2020-01-13	2020-01-15	100,000	$4.00	$400.0K	0	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	S Sale	2020-01-13	2020-01-15	50,000	$5.00	$250.0K	0	SEC↗
TAYTON-MARTIN HELEN KATRINA	Chief Business Officer	S Sale	2020-01-13	2020-01-15	50,000	$4.00	$200.0K	0	SEC↗
Rawcliffe Adrian	Chief Executive Officer	S Sale	2020-01-06	2020-01-07	5,900	$1.20	$7.1K	5,804	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2020-01-06	2020-01-07	3,731	$1.20	$4.5K	5,632	SEC↗
Lunger John	Chief Patient Supply Officer	S Sale	2020-01-06	2020-01-07	1,148	$1.20	$1.4K	1,677	SEC↗
Rawcliffe Adrian	CEO and CFO	A Award deriv	2019-09-01	2019-09-03	628,872	—	$0	628,872	SEC↗
Rawcliffe Adrian	CEO and CFO	A Award deriv	2019-09-01	2019-09-03	140,448	—	$0	140,448	SEC↗
Amado Rafael	President, R&D	S Sale	2019-08-06	2019-08-07	11,043	$2.06	$22.7K	17,237	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2019-08-01	2019-08-05	839,568	—	$0	839,568	SEC↗
Lunger John	Chief Patient Supply Officer	A Award deriv	2019-08-01	2019-08-05	187,500	—	$0	187,500	SEC↗
Alleva Lawrence M	Director	A Award deriv	2019-07-02	2019-07-03	271,209	—	$0	271,209	SEC↗
Duncan Barbara Gayle	Director	A Award deriv	2019-07-02	2019-07-03	124,000	—	$0	124,000	SEC↗
Kerr Giles Francis Bertram	Director	A Award deriv	2019-07-02	2019-07-03	124,000	—	$0	124,000	SEC↗
Furey John	Director	A Award deriv	2019-07-02	2019-07-03	240,541	—	$0	240,541	SEC↗
Sigal Charles Elliott	Director	A Award deriv	2019-07-02	2019-07-03	234,407	—	$0	234,407	SEC↗
Zaks Tal Zvi	Director	A Award deriv	2019-07-02	2019-07-03	124,000	—	$0	124,000	SEC↗
Behbahani Ali	Director	A Award deriv	2019-07-02	2019-07-03	234,407	—	$0	234,407	SEC↗
MOTT DAVID M	Director, 10% Owner	A Award deriv	2019-07-02	2019-07-03	350,947	—	$0	350,947	SEC↗
Rawcliffe Adrian	Chief Financial Officer	A Award deriv	2019-06-27	2019-06-27	628,872	—	$0	628,872	SEC↗
Rawcliffe Adrian	Chief Financial Officer	A Award deriv	2019-06-27	2019-06-27	140,448	—	$0	140,448	SEC↗
Noble James	Chief Executive Officer	M Exercise	2019-05-16	2019-05-17	1,773,100	$0.14	$248.2K	1,773,100	SEC↗
Rawcliffe Adrian	Chief Financial Officer	S Sale	2019-01-14	2019-01-16	3,084	$5.37	$16.6K	3,318	SEC↗
Amado Rafael	President, R & D	S Sale	2019-01-14	2019-01-16	3,028	$5.37	$16.3K	4,974	SEC↗
Bertrand William C JR	Chief Operating Officer	S Sale	2019-01-14	2019-01-16	2,271	$5.37	$12.2K	3,731	SEC↗
Binder-Scholl Gwendolyn Knowlt	Chief Technology Officer	S Sale	2019-01-14	2019-01-16	1,514	$5.37	$8.1K	2,487	SEC↗
Noble James	Chief Executive Officer	A Award deriv	2019-01-04	2019-01-08	561,792	—	$0	561,792	SEC↗
Noble James	Chief Executive Officer	A Award deriv	2019-01-04	2019-01-08	2,515,536	—	$0	2,515,536	SEC↗
Amado Rafael	President, R & D	A Award deriv	2019-01-04	2019-01-08	1,006,224	—	$0	1,006,224	SEC↗
Amado Rafael	President, R & D	A Award deriv	2019-01-04	2019-01-08	224,724	—	$0	224,724	SEC↗
Rawcliffe Adrian	Chief Financial Officer	A Award deriv	2019-01-04	2019-01-08	1,257,744	—	$0	1,257,744	SEC↗